Chet is an expert medicinal chemistry drug hunter with more than 20 years of experience from Novartis, Cerulean, Cubist and Ariad in R&D drug discovery strategy and execution across small molecule, natural product/peptide and nanoparticle drug conjugate modalities. He has led cross-functional teams to successfully discover and develop multiple development candidates, including 6 clinical and marketed compounds. He was a co-inventor of Iclusig® and EluNIR™). He has a track record of building and managing project teams from hit to lead, lead optimization, development candidate, to IND, across oncology and other therapeutic areas. Chet received his Ph.D. in organic chemistry from Yale University and is a co-author of over 80 publications, patent applications and issued patents.